Evidence map›Paper›PMID 27363808›Full record

ArticleScientific reports2016

Indexing Effects of Copy Number Variation on Genes Involved in Developmental Delay.

Mohammed Uddin, Giovanna Pellecchia, Bhooma Thiruvahindrapuram, Lia D'Abate, Daniele Merico, Ada Chan, Mehdi Zarrei, Kristiina Tammimies, Susan Walker, Matthew J Gazzellone and 19 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 9 institutions in 4 countries.

Mohammed UddinThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Giovanna PellecchiaThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Bhooma ThiruvahindrapuramThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Lia D'AbateThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Daniele MericoThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Ada ChanThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Mehdi ZarreiThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Kristiina TammimiesCenter of Neurodevelopmental Disorders (KIND), Neuropsychiatric Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Susan WalkerThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Matthew J GazzelloneThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Thomas NalpathamkalamThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Ryan K C YuenThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Koenraad DevriendtCenter for Human Genetics, University of Leuven, Leuven, Belgium.
Géraldine MathonnetCHU Sainte-Justine, University de Montreal, Montreal, Quebec, Canada.
Emmanuelle LemyreCHU Sainte-Justine, University de Montreal, Montreal, Quebec, Canada.
Sonia NizardCHU Sainte-Justine, University de Montreal, Montreal, Quebec, Canada.
Mary ShagoGenome Diagnostics, Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
Ann M Joseph-GeorgeGenome Diagnostics, Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
Abdul NoorDepartment of Pathology and Laboratory Medicine, Division of Diagnostic Medical Genetics, Mount Sinai Hospital, Toronto, Ontario, Canada.
Melissa T CarterDepartment of Genetics, The Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.
Grace YoonDivision of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario M5G 2L3, Canada.
Peter KannuDivision of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario M5G 2L3, Canada.
Frédérique TihyCHU Sainte-Justine, University de Montreal, Montreal, Quebec, Canada.
Erik C ThorlandCytogenetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Christian R MarshallThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Janet A BuchananThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Marsha SpeevakDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Dimitri J StavropoulosGenome Diagnostics, Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
Stephen W SchererThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Hospital for Sick Children · CASickKids Foundation · CACentre Hospitalier Universitaire Sainte-Justine · CAUniversity of Toronto · CAChildren's Hospital of Eastern Ontario · CAKarolinska Institutet · SEKU Leuven · BEMayo Clinic · USMount Sinai Hospital · CA

Funding

CIHR
6 · The paper itself

Abstract

A challenge in clinical genomics is to predict whether copy number variation (CNV) affecting a gene or multiple genes will manifest as disease. Increasing recognition of gene dosage effects in neurodevelopmental disorders prompted us to develop a computational approach based on critical-exon (highly expressed in brain, highly conserved) examination for potential etiologic effects. Using a large CNV dataset, our updated analyses revealed significant (P < 1.64 × 10(-15)) enrichment of critical-exons within rare CNVs in cases compared to controls. Separately, we used a weighted gene co-expression network analysis (WGCNA) to construct an unbiased protein module from prenatal and adult tissues and found it significantly enriched for critical exons in prenatal (P < 1.15 × 10(-50), OR = 2.11) and adult (P < 6.03 × 10(-18), OR = 1.55) tissues. WGCNA yielded 1,206 proteins for which we prioritized the corresponding genes as likely to have a role in neurodevelopmental disorders. We compared the gene lists obtained from critical-exon and WGCNA analysis and found 438 candidate genes associated with CNVs annotated as pathogenic, or as variants of uncertain significance (VOUS), from among 10,619 developmental delay cases. We identified genes containing CNVs previously considered to be VOUS to be new candidate genes for neurodevelopmental disorders (GIT1, MVB12B and PPP1R9A) demonstrating the utility of this strategy to index the clinical effects of CNVs.

Indexed as

DNA Copy Number VariationsAdaptor Proteins, Signal TransducingAdultBrainCell Cycle ProteinsChildDevelopmental DisabilitiesFemaleGene Expression ProfilingGene Expression Regulation, DevelopmentalGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMaleProteomicsAdaptor Proteins, Signal TransducingCell Cycle ProteinsGIT1 protein, human

Identifiers

PMID27363808
PMCPMC4929460
OpenAlexW2473990461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.